MarketPulse
R

$RMD

5 articles found
5 positive
0 negative
0 neutral
Investing.comInvesting.com··David Wagner

Nine Stocks Poised to Defy 'Sell in May' as Market Hits New Highs

Record earnings beats and 27% growth challenge the 'Sell in May' strategy in 2026, with selective stock opportunities offering upside potential despite geopolitical risks.
DXCMRMDstock markethealthcare stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Sleep Apnea Device Market Poised for 7% Annual Growth Through 2034

Global sleep apnea devices market expected to grow 7.05% annually through 2034, driven by rising prevalence and technological advances in CPAP and BiPAP devices.
RMDPHGmarket growthtelemedicine
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Respiratory Care Device Market to Double to $47.5B by 2034 on Disease Surge

Global respiratory care devices market projected to grow 8% annually to $47.5B by 2034, driven by chronic disease prevalence and home healthcare demand.
MDTRMDPHGGEHCmarket growthCOPD
The Motley FoolThe Motley Fool··Selena Maranjian

ResMed Eyes Growth Despite Healthcare Headwinds With Valuation Upside

ResMed trades at a 25% valuation discount despite 11% revenue growth and expanding digital health operations in 140+ countries, though Medicare reimbursement risks persist.
RMDstock valuationgrowth stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Anti-Snoring Device Market Poised to Double by 2033 Amid Health Awareness Surge

Global anti-snoring devices market projected to nearly double to $3.36 billion by 2033, driven by obesity, health awareness, and technological advances.
GSKRMDPHGe-commercemarket growth